Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marie-Elise Bonnet"'
Autor:
Sylvie Remaud, Silvia Alejandra López-Juárez, Anne-Laure Bolcato-Bellemin, Patrick Neuberg, Fabrice Stock, Marie-Elise Bonnet, Rym Ghaddab, Marie Stéphanie Clerget-Froidevaux, Jacqueline Pierre-Simons, Patrick Erbacher, Barbara A Demeneix, Ghislaine Morvan-Dubois
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
RNA interference (RNAi) is a major tool for basic and applied investigations. However, obtaining RNAi data that have physiological significance requires investigation of regulations and therapeutic strategies in appropriate in vivo settings. To exami
Externí odkaz:
https://doaj.org/article/610d54fd0518414b9ddfee3da120af2e
Autor:
Bernard S. Lopez, Najat Magroun, Giuditta Illuzzi, Carole Beck, Valérie Schreiber, Laurent Gauthier, Anbazhagan Rajendran, Françoise Dantzer, Marie-Elise Bonnet, Philippe Rondé, Ralph Scully, François D. Boussin, Christian Boehler, Josée Guirouilh Barbat
Publikováno v:
Nucleic Acids Research
Nucleic Acids Research, Oxford University Press, 2014, 42, pp.5616-5632
Nucleic Acids Research, 2014, 42 (9), pp.5616-5632. ⟨10.1093/nar/gku174⟩
Nucleic Acids Research, Oxford University Press, 2014, 42 (9), pp.5616-5632. ⟨10.1093/nar/gku174⟩
Nucleic Acids Research, Oxford University Press, 2014, 42, pp.5616-5632
Nucleic Acids Research, 2014, 42 (9), pp.5616-5632. ⟨10.1093/nar/gku174⟩
Nucleic Acids Research, Oxford University Press, 2014, 42 (9), pp.5616-5632. ⟨10.1093/nar/gku174⟩
The repair of toxic double-strand breaks (DSB) is critical for the maintenance of genome integrity. The major mechanisms that cope with DSB are: homologous recombination (HR) and classical or alternative nonhomologous end joining (C-NHEJ versus A-EJ)
Autor:
Patrick Erbacher, Anne-Laure Bolcato-Bellemin, Marie-Elise Bonnet, Jean-Paul Behr, Gaëlle Creusat
Publikováno v:
Proceedings of the National Academy of Sciences. 104:16050-16055
siRNA delivery to cells offers a convenient and powerful means of gene silencing that bypasses several barriers met by gene delivery. However, nonviral vectors, and especially polymers, form looser complexes with siRNA than with plasmid DNA. As a con
Autor:
Patrick Erbacher, Omar Zounib, Valérie Kedinger, Jean-Paul Behr, Pattabhiraman Shankaranarayanan, Marie-Elise Bonnet, Mélanie Messmer, Aline Meulle, Jean-Baptiste Gossart, Elodie Benoit, Anne-Laure Bolcato-Bellemin
Publikováno v:
BMC Cancer
Background Melanoma represents one of the most aggressive and therapeutically challenging malignancies as it often gives rise to metastases and develops resistance to classical chemotherapeutic agents. Although diverse therapies have been generated,
Autor:
Omar Zounib, Nathalie Lenne-Samuel, Marie-Elise Bonnet, Mélanie Messmer, Patrick Erbacher, Aline Meulle, Valérie Kedinger, Elodie Benoit, Jean-Paul Behr, Valérie Moreau, Jean-Baptiste Gossart, Anne-Laure Bolcato-Bellemin
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 170(2)
RNA interference allows the design of new inhibitors that target deregulated pathways in cancer. However systemic delivery of siRNA for the treatment of solid tumors still remains an issue. In our study, in order to suppress the progression of lung c
Autor:
Patrick Neuberg, Patrick Erbacher, Marie-Elise Bonnet, Rym Ghaddab, Ghislaine Morvan-Dubois, Silvia Alejandra López-Juárez, Fabrice Stock, Anne-Laure Bolcato-Bellemin, Jacqueline Pierre-Simons, Barbara A. Demeneix, Sylvie Remaud, Marie Stéphanie Clerget-Froidevaux
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
Molecular Therapy. Nucleic Acids
Molecular Therapy — Nucleic Acids; Vol 2
Molecular Therapy. Nucleic Acids
Molecular Therapy — Nucleic Acids; Vol 2
RNA interference (RNAi) is a major tool for basic and applied investigations. However, obtaining RNAi data that have physiological significance requires investigation of regulations and therapeutic strategies in appropriate in vivo settings. To exami
Publikováno v:
Pharmaceutical research. 25(12)
The success of nucleic acid therapies depends upon delivery vehicle's ability to selectively and efficiently deliver therapeutic nucleic acids to target organ with minimal toxicity. The cationic polymer polyethylenimine (PEI) has been widely used for